(Reuters) -The U.S. health regulator on Tuesday approved Australian drugmaker CSL Ltd and partner Uniqure NV's gene therapy for hemophilia B, ...
https://www.google.com/url?rct=j&sa=t&url=https://wtvbam.com/2022/11/22/fda-approves-csl-gene-therapy-for-hemophilia/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AOvVaw0jn7k834RvyzCV7IAEVVar
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.